| Market Capitalization (Millions $) |
112 |
| Shares
Outstanding (Millions) |
23 |
| Employees |
8 |
| Revenues (TTM) (Millions $) |
8 |
| Net Income (TTM) (Millions $) |
-22 |
| Cash Flow (TTM) (Millions $) |
21 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Coya Therapeutics Inc is a biotechnology company that focuses on developing innovative therapeutics for the treatment of cancer. They aim to address the challenges faced by conventional cancer therapies by utilizing a unique approach that combines multiple treatment modalities, such as targeted drugs, immunotherapies, and gene therapies.
The company's research and development efforts are centered around identifying and targeting specific cancer cell signaling pathways that play a crucial role in tumor growth and survival. By understanding the underlying mechanisms that drive cancer progression, Coya Therapeutics aims to develop novel therapies that can selectively and effectively target cancer cells while minimizing side effects on healthy tissues.
Coya Therapeutics also places a strong emphasis on precision medicine, utilizing advanced genomic technologies to identify specific genetic alterations in tumors that can be targeted with personalized therapies. This approach aims to tailor treatments to each patient's unique genetic profile, maximizing treatment efficacy and minimizing the risk of adverse events.
Overall, Coya Therapeutics Inc is dedicated to advancing the field of cancer therapeutics through innovative research and development, with the ultimate goal of improving patient outcomes and quality of life.
Company Address: 5850 San Felipe St., Suite 500 Houston 77057 TX
Company Phone Number: 587-8170 Stock Exchange / Ticker: NASDAQ COYA
|
1.68% 